Trimurthi Drugs & Pharmaceuticals has informed that the board of directors of the company at its meeting held on July 21, 2012, has considered and approved the raising of funds by issue of convertible warrants subject to approval of shareholders in ensuing annual general meeting and after detailed discussion, recommended the dividend of 3% on the equity shares for the year 2011-12.
The above information is a part of company's filings submitted to BSE.
